[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565206":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":15,"responsibleParty":32,"collaborators":7,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":7,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":18,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":58},{"fullName":5,"class":6},"Centro di Riferimento Oncologico - Aviano","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Maurizio Mascarin, MD","CONTACT","0434 659 536","+39","mascarin@cro.it",[16],{"facility":17,"status":18,"city":19,"state":20,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Centro di Riferimento Oncologico","RECRUITING","Aviano","Pordenone","33081","Italy","IT",{"type":25,"coordinates":26},"Point",[27,28],12.59472,46.07056,{"lat":28,"lon":27},[31],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100565206","retrospective-perspective-observational-cohort-study-on-toxicity-and-efficacy-of-radiotherapy-in-pediatric-and-adult-patients-with-pediatric-histology-treated-at-the-pediatric-radiotherapy-of-the-cro-in-aviano-100565206",false,"NCT06639165","Retrospective-perspective Observational Cohort Study on Toxicity and Efficacy of Radiotherapy in Pediatric and Adult Patients With Pediatric Histology Treated at the Pediatric Radiotherapy of the CRO in Aviano","RADIOPED","Inclusion Criteria:\n\n* Pediatric, adolescent, and young adult (\\\u003C25 years old) patients with malignant neoplasm\n* Adult patients (≥25 years) with malignant neoplasm with histology typical of pediatric age but rarely also found in adults and typically treated wherever possible in pediatric protocols (mainly: Central nervous system malignancies such as medulloblastomas and other embryonal tumors, ependymomas, and germ cell tumors; soft tissue and bone sarcomas such as rhabdomyosarcomas and Ewing's sarcomas; nephroblastomas; neuroblastomas)\n* Underwent radiation treatment at the Pediatric Radiotherapy Unit of the CRO in Aviano\n* Between October 24, 1991, and September 30, 2020, with regard to the retrospective phase of the study, and between October 1, 2020, and September 30, 2030, with regard to the prospective phase of the study\n* And who provide informed consent to the study if alive and traceable at the time of enrollment with regard to the retrospective phase of the study and necessarily with regard to the prospective phase. Regarding deceased or alive but untraceable patients enrollable in the retrospective phase of the study, since these are patients who had already given consent to data processing at the time of the radiation therapy being analyzed and registration\u002Fenrollment in any specific treatment\u002Fresearch protocols, no new consent is required for the study\n\nExclusion Criteria:\n\n\\- Anything not covered in the inclusion criteria","ALL",{"count":43,"type":44},280,"ESTIMATED","OBSERVATIONAL","Radiotherapy key role in pediatric oncology, despite the potential side effects especially in the long term, including the risk of radioinduced second cancers.\n\nVery rarely malignant neoplasms typical of children and adolescents may present in adulthood, historically with a worse outcome, but for some of these histologies demonstrated recent results overlapping with those in pediatric age when treated with strategies similar to pediatric protocols and similar radiotherapy.\n\nLong-term data on outcome and incidence of potential toxicity late radiation therapy in these populations almost exclusively from epidemiologic studies or retrospective case series. Prospective data are lacking, particularly in patients treated with IMRT and specifically with certain IMRT modalities such as Helical Tomotherapy, for which the CRO pediatric radiotherapy has documented experience. The main objective is to evaluate the short- and long-term toxicity secondary to radiotherapy performed at the Pediatric Radiotherapy of the CRO in Aviano, with specific subgroup analyses aimed at highlighting any differences mainly by age, pathology and radiotherapy technique.",[48],"Radiation Toxicity","2024-10-10",{"date":51,"type":52},"2024-10-15","ACTUAL",{"date":54,"type":52},"2020-10-01",{"date":56,"type":44},"2030-09-30",{"name":5,"class":6},1]